Novel circular RNA, hsa_circ_0025039 promotes cell growth, invasion and glucose metabolism in malignant melanoma via the miR-198/CDK4 axis

被引:50
作者
Bian, Donghui [1 ]
Wu, Yan [2 ]
Song, Guodong [3 ]
机构
[1] Gen Hosp Jinan Mil Command, Dept Burns & Plast Surg, 25 Shifan Rd, Jinan 250031, Shandong, Peoples R China
[2] Shandong Univ, Jinan Cent Hosp, Med Image Ctr, 105 Jiefang Rd, Jinan 250013, Shandong, Peoples R China
[3] Shandong Univ, Jinan Cent Hosp, Dept Burns & Plast Surg, 105 Jiefang Rd, Jinan 250013, Shandong, Peoples R China
关键词
Circular RNA; Malignant melanoma; has_circ_0025039; Sponge; miR-198; CDK4; MIRNA SPONGES; CANCER; EXPRESSION; PROGRESSION; MICRORNAS; LUNG; PROLIFERATION; SURVIVAL; CDK4/6;
D O I
10.1016/j.biopha.2018.08.152
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Malignant melanoma, a tumor derived from melanocytes, shows severe drug resistance and prompt metastasis, causing a serious threat to human health. Circular RNAs (circRNAs) are widely expressed in mammals and have been indicated to play important roles in tumorigenesis. In the present study, we analyzed the variability of circRNAs in malignant melanoma by microarray and identified six differentially expressed circRNAs. In particular, we found that hsa_circ_0025039, which is formed by FOXM1 exons, is significantly upregulated in melanoma. In vitro, the knockdown of circ_0025039 inhibited cell proliferation, colony formation ability, invasion and glucose metabolism in melanoma cells. Additionally, we identified miR-198 as a direct target of hsa_circ_0025039. Furthermore, we demonstrated that hsa_circ_0025039 regulates CDK4 expression by sponging miR-198. In vivo study indicated that the silencing of hsa_circ_0025039 inhibits melanoma tumor formation and downregulates miR-198 and CDK4 expression. Taken together, our data showed that circ_0025039 promotes cell growth, invasion and glucose metabolism in malignant melanoma by sponging miR-198 and regulating CDK4.
引用
收藏
页码:165 / 176
页数:12
相关论文
共 42 条
[1]   Cutaneous Malignant Melanoma: Update on Diagnostic and Prognostic Biomarkers [J].
Abbas, Ossama ;
Miller, Daniel D. ;
Bhawan, Jag .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2014, 36 (05) :363-379
[3]  
Armand-Labit Virginie, 2017, BioMolecular Concepts, V8, P61, DOI 10.1515/bmc-2017-0002
[4]   CDK4 in lung, and head and neck cancers in old age: evaluation as a biomarker [J].
Banerjee, J. ;
Pradhan, R. ;
Gupta, A. ;
Kumar, R. ;
Sahu, V. ;
Upadhyay, A. D. ;
Chaterjee, P. ;
Dwivedi, S. ;
Dey, S. ;
Dey, A. B. .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (05) :571-578
[5]  
Belter B., 2017, Cutaneous Melanoma: Etiology and Therapy
[6]   Novel biomarkers in malignant melanoma [J].
Bosserhoff, AK .
CLINICA CHIMICA ACTA, 2006, 367 (1-2) :28-35
[7]   Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and present [J].
Casimiro, Mathew C. ;
Velasco-Velazquez, Marco ;
Aguirre-Alvarado, Charmina ;
Pestell, Richard G. .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (03) :295-304
[8]   MicroRNAs in lung cancer [J].
Castro, Diana ;
Moreira, Marcia ;
Gouveia, Alexandra Monteiro ;
Pozza, Daniel Humberto ;
De Mello, Ramon Andrade .
ONCOTARGET, 2017, 8 (46) :81679-81685
[9]   CircRNA_100782 regulates pancreatic carcinoma proliferation through the IL6-STAT3 pathway [J].
Chen, Genwen ;
Shi, Yanting ;
Zhang, Yu ;
Sun, Jianyong .
ONCOTARGETS AND THERAPY, 2017, 10 :5783-5794
[10]   RETRACTED: circRNA_100290 plays a role in oral cancer by functioning as a sponge of the miR-29 family (Retracted article. See vol. 38, pg. 5750, 2019) [J].
Chen, L. ;
Zhang, S. ;
Wu, J. ;
Cui, J. ;
Zhong, L. ;
Zeng, L. ;
Ge, S. .
ONCOGENE, 2017, 36 (32) :4551-4561